Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's New Guideline For Drug Pricing Favors Innovation And First-to-market Generics

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - The National Development and Reform Commission, China's powerful economic regulatory body, is collecting feedback from industry for a new drug pricing guideline, which details new rules for setting drug prices in China's changing healthcare system

You may also be interested in...



2013 China Outlook: Year Of The Snake To Bring Twists And Turns For Pharma

A sharp expansion in China’s Essential Drug List along with the National Drug Reimbursement List are among the twists and turns expected as the Year of the Snake is ushered in this February.

China To Further Squeeze Distribution Margins And Limit Drug Markups In Hospitals

The National People’s Congress and Chinese Peoples’ Political Consultative Conference will bring in March a variety of new policies and regulations that will impact the industry.

China To Further Squeeze Distribution Margins And Limit Drug Markups In Hospitals

The National People’s Congress and Chinese Peoples’ Political Consultative Conference will bring in March a variety of new policies and regulations that will impact the industry.

Related Content

UsernamePublicRestriction

Register

SC075059

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel